Vest Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Vest Financial's REGN Position: Q2 2026 in Review
Vest Financial increased its Regeneron Pharmaceuticals (REGN) stake by 150% in Q2 2026, buying an estimated $19.8M and bringing the position to 48,482 shares worth $30.2M. The position accounts for 0.32% of the portfolio, ranked #124.
Vest Financial first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Vest Financial held 48,482 shares of Regeneron Pharmaceuticals worth $30.2M as of Q2 2026.
- Vest Financial bought 29,119 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $19.8M.
- Regeneron Pharmaceuticals made up 0.32% of Vest Financial's portfolio in Q2 2026, its #124 holding.
- Vest Financial first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Vest Financial's 13F filing for Q2 2026, filed 24 Jul 2026.